Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved specifically for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, sleep apnea, or dyslipidemia
BPC-157 has shown strong anti-inflammatory activity by modulating nitric oxide pathways and suppressing pro-inflammatory cytokines like TNF- and IL-6
Food and Drug Administration (FDA) doesnt regulate berberine for safety and effectiveness
For patients experiencing injection site reactions, several practical strategies can minimize discomfort
injectable decision , exact dose ladders for each route, DIY 12% serum formulation , the healing-trio stack , half-life and cycling logic, what to avoid layering it with (hint: straight ascorbic acid and benzoyl peroxide), and the handful of real side effects and contraindications Wilson's disease being the one hard stop
Oct 6 2015;163(7):519-528